Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
42,149
+1,761
+4% +$38.9K ﹤0.01% 1827
2026
Q1
$590K Buy
40,388
+26,431
+189% +$388K ﹤0.01% 2370
2025
Q4
$176K Sell
13,957
-18,170
-57% -$268K ﹤0.01% 3203
2025
Q3
$494K Buy
+32,127
New +$518K ﹤0.01% 2437
2025
Q2
Sell
-13,287
Closed -$254K 3656
2025
Q1
$254K Sell
13,287
-800
-6% -$17.5K ﹤0.01% 2791
2024
Q4
$336K Buy
14,087
+398
+3% +$11.1K ﹤0.01% 2525
2024
Q3
$383K Sell
13,689
-931
-6% -$26.3K ﹤0.01% 2365
2024
Q2
$382K Buy
+14,620
New +$304K ﹤0.01% 2260

Other funds holding RXO

Mariner's RXO Position: Q2 2026 in Review

Mariner increased its RXO (RXO) stake by 4.4% in Q2 2026, buying an estimated $38.9K and bringing the position to 42,149 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1827.

Mariner first reported a position in RXO in Q2 2024 and has held it in 8 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Mariner held 42,149 shares of RXO worth $1.16M as of Q2 2026.
  • Mariner bought 1,761 RXO shares in Q2 2026, an estimated $38.9K.
  • RXO made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1827 holding.
  • Mariner first reported a position in RXO in Q2 2024 and has held it in 8 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.